We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+13.92%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$419M
AUM Growth
+$51.7M
Cap. Flow
+$5.75M
Cap. Flow %
1.37%
Top 10 Hldgs %
31.11%
Holding
110
New
12
Increased
24
Reduced
47
Closed
9

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.11M
2
CPRI icon
Capri Holdings
CPRI
+$5.87M
3
MCK icon
McKesson
MCK
+$3.46M
4
COR icon
Cencora
COR
+$3.16M
5
GGG icon
Graco
GGG
+$3.13M

Sector Composition

Rank Sector Weight
1 Healthcare 28.9%
2 Financials 15.15%
3 Industrials 14.25%
4 Consumer Discretionary 10.89%
5 Technology 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HOLX
101
DELISTED
Hologic
HOLX
$204K 0.05%
9,150
-3,000
-25% -$66.1K
EBAY icon
102
eBay
EBAY
$48.6B
-221,681
Closed -$5.21M
ELME
103
Elme Communities
ELME
$132M
-8,300
Closed -$210K
TDC icon
104
Teradata
TDC
$2.68B
-42,800
Closed -$2.37M
TS icon
105
Tenaris
TS
$29.1B
-70,400
Closed -$3.29M
KRFT
106
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
-64,423
Closed -$3.38M
WCRX
107
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
-214,400
Closed -$4.96M
SPLS
108
DELISTED
Staples Inc
SPLS
-10,069
Closed -$148K
AGN
109
DELISTED
Allergan Inc
AGN
-21,390
Closed -$1.94M
GCVRZ
110
DELISTED
Sanofi Contingent Value Rights
GCVRZ
-40,300
Closed -$81K

Similar funds

De Burlo Group's Q4 2013 Portfolio in Review

As of Q4 2013, De Burlo Group held 110 positions worth $419M, up 14% from $367M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

De Burlo Group's Q4 2013 filing shows 12 new, 24 increased, 47 reduced and 9 closed positions. Its largest new stake was Celgene Corp: 89,800 shares worth $7.59M. The largest sale was Alexion Pharmaceuticals, an estimated $6.63M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.

  • De Burlo Group's largest Q4 2013 buy was Celgene Corp: 89,800 shares worth $7.59M.
  • De Burlo Group added most to McKesson in Q4 2013, an estimated $3.46M increase.
  • De Burlo Group's biggest Q4 2013 reduction was Alexion Pharmaceuticals, cutting an estimated $6.63M.
  • De Burlo Group fully exited eBay in Q4 2013, selling an estimated $5.21M.
  • De Burlo Group's ten largest holdings make up 31% of its $419M portfolio in Q4 2013.
  • De Burlo Group opened 12 new positions and closed 9 in Q4 2013.
  • De Burlo Group's portfolio value rose 14% quarter-over-quarter to $419M.

Based on De Burlo Group's 13F filing for Q4 2013, filed 7 Feb 2014.